Elan Mergers and Acquisitions Summary

Healthcare Services Company

Elan has acquired 2 companies of its own. A total of 2 acquisitions came from private equity firms. It has also divested 1 asset.

Elan’s largest acquisition to date was in 2000, when it acquired Dura Pharmaceuticals for $1.8B. It’s largest disclosed sale occurred in 2013, when it sold TYSABRI to Biogen for $3.3B. Elan has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include business services (50%) and healthcare services (50%).

Join Mergr and gain access to Elan’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the healthcare services sector.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity2
    • M&A Sell Activity1
  • Total Sectors Invested 2
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 3
  • M&A Advisors 4

Elan Corp. plc

Treasury Building Lower Grand Canal Street,
Dublin,
Ireland,
+353-1-7094000
www.elan.com

Elan is a biotechnology company, headquartered in Dublin, Ireland, committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world. It focused on discovering and developing advanced therapies in neurodegenerative and autoimmune diseases.


M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (0.0/yr) # 2 - - - - - 2
vol $1.8B $1.8B
Sell (0.0/yr) # 1 - - - - - 1
vol $3.3B $3.3B
  3

Most Recent M&A

Company Date Value Type
TYSABRI 2013-02-06 3.3B USD Divestiture
, United States · www.tysabri.com
Pharma Marketing 2003-01-17 - Add-on Acquisition
Hamilton, Bermuda
Dura Pharmaceuticals, Inc. 2000-11-09 1.8B USD Add-on Acquisition
San Diego, California
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Business Services 1 (50%) - - -
Healthcare Services 1 (50%) 1.8B (100%) - -
Life Science - - 1 (100%) 3.3B (100%)
Total 2 $1.8B 1 $3.3B

By Geo

State/Country Buy Value Sell Value
United States 1 1.8B 1 3.3B
  California 1 1.8B - -
Bermuda 1 - - -
Domestic - - - -
Cross-border 2 (100%) 1.8B (100%) 1 (100%) 3.3B (100%)
Total 2 $1.8B 1 $3.3B

Top M&A Advisors

Financial Deals
Citigroup Investment Banking
1
Ondra LLP (Ondra Partners)
1
Legal Deals
Cadwalader, Wickersham & Taft LLP
1
A&L Goodbody
1

Deal Values

buy # Total
> $1B 1 $1.8B
TOTAL $1.8B
Largest Dura Pharmaceuticals, Inc.
$1.8B (2000-11-09)
sell # Total
> $1B 1 $3.3B
TOTAL $3.3B
Largest TYSABRI
$3.3B (2013-02-06)

M&A Connections

Deals %
Acquired from
PE Firm(s)
100%
2 100%
Divested to
Strategic(s)
100%
1 100%

 Subscribe to unlock this and 155,627
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.0K Private Equity Firms
  • 144K M&A Transactions
  • 152K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.1K M&A Advisors
    (Investment Banks and Law Firms)
  • 45K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.